SEVILLE, 12 Jan. (EUROPA PRESS) –
The Big Data Area of the Computational Medicine Platform (PMC) of Fundación Progreso y Salud co-leads a project that aims to obtain a remission prediction model for inflammatory bowel disease (IBD) in the medium and long term.
The work, in which the Big Data Area participates together with professionals from the Hospital Pharmacy Unit and the Digestive System Service of the Virgen Macarena University Hospital in Seville, has been awarded the Scholarship of the Andalusian Inflammatory Bowel Disease Working Group of the Andalusian Society of Digestive Pathology (SAPD).
Specifically, according to a statement, the team that has developed this clinical decision support system, currently in the training phase, includes the pharmacists Jaime Cordero, Vicente Merino and Alicia Aguado; and the digestives Federico Argüelles, Carmen Vías, Pilar Navajas and Luisa Castro. The entire clinical team belongs to the Virgen Macarena University Hospital. They are joined by the coordinator of the Big Data Area of the PMC, Miguel Ángel Armengol, PhD in Biomedical Engineering, who provides the technical basis for the development of the project.
The research group has developed a decision-making support tool in the clinical setting that –using the machine-learning system– makes it possible to predict the response to medications of new patients and current ones in future situations.
According to the coordinator of the Big Data Area of the Computational Medicine Platform, Miguel Ángel Armengol, “this type of project is possible thanks to the SSPA’s own and interoperable electronic medical record, Diraya, which stores information from more than 30 hospitals, 1,000 primary care centers and more than 14 million patients and that can be exploited thanks to BPS and his team”.
This favorable context has given rise to the Praetoria initiative (Andalusian platform for the development of clinical decision support systems), one of the lines of work of the Big Data Area, which seeks to offer solutions to unmet needs of the health system through of the development of different decision support systems, like this one that has been awarded.
This particular project is linked to digestive diseases. Inflammatory bowel disease (IBD) encompasses Crohn’s disease (CD) and ulcerative colitis (UC); both are chronic diseases. It is estimated that since 2010, IBD affects more than 2.5 million in Europe.